During the past decade, Ark Clinical Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 8 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ark Clinical Research" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Vaxart" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ark Clinical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ark Clinical Research" are "COVID-19" (7 trials), "Influenza, Human" (2 trials), "Acute Respiratory Infection" (1 trials), "Allergic Contact Dermatitis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Ark Clinical Research" in a lesser frequency.

Most popular intervention types in "Ark Clinical Research" are "Drug" (15 trials), "Biological" (11 trials), "Other" (6 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Ad26.COV2.S" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ark Clinical Research" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Ark Clinical Research". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ark Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ark Clinical Research, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".